Intercept Pharmaceuticals, Inc.

... ...
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. -1.74%26.5314.1%$156.11m
HZNPHorizon Therapeutics Plc -4.51%74.975.6%$145.18m
ACRSAclaris Therapeutics, Inc. -0.91%17.484.7%$128.70m
BHCBausch Health Cos., Inc. -1.74%26.530.0%$109.30m
CTLTCatalent, Inc. -2.08%113.322.1%$104.54m
JAZZJazz Pharmaceuticals Plc -2.88%166.052.4%$86.52m
SAVACassava Sciences, Inc. 23.92%19.430.0%$69.29m
AMRNAmarin Corp. Plc -1.06%7.481.5%$62.88m
UTHRUnited Therapeutics Corp. -2.66%164.8514.1%$59.11m
ISRIsoRay, Inc. -4.09%2.112.5%$56.26m
GWPHGW Pharmaceuticals Plc 4.77%150.236.1%$55.26m
PRGOPerrigo Co. Plc 0.00%44.506.8%$53.91m
ACSTAcasti Pharma, Inc. -4.20%0.730.2%$53.14m
ARGXargenx SE -4.55%300.990.0%$50.83m
ICPTIntercept Pharmaceuticals, Inc. 1.93%33.7816.8%$43.62m

Company Profile

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.